You are here: Industry Insights > SARS-CoV-2

News List

Qualigen Releases FastPack® SARS-CoV-2 Antibody Diagnostic Test americanpharmaceuticalreview
June 08, 2020
Qualigen Therapeutics has released a pre-launch supply of its proposed FastPack® SARS-CoV-2 IgG Immunoassay diagnostic test kits to the University of Louisville to conduct validation studies ...
Sun Pharma initiates Phase II clinical trial on AQCH as potential treatment for COVID-19 expresspharma
June 08, 2020
AQCH is the first phytopharmaceutical drug approved for clinical trial by DCGI for COVID-19 and has shown anti-SARS-CoV-2 effects in in-vitro studies.
Memo Therapeutics discovers neutralising antibodies against Covid-19 pharmaceutical-technology
June 05, 2020
Switzerland-based Memo Therapeutics has discovered multiple SARS-CoV-2 neutralising antibodies with the potential for development as immunotherapy against Covid-19.
Codiak BioSciences collaborates with Ragon Institute to evaluate exoVACC vaccine platform in SARS-Co pharmaceutical-business-review
June 04, 2020
Codiak BioSciences announced that it has entered into two strategic collaborations with the Ragon Institute of MGH, MIT and Harvard to investigate ...
FDA Provides New Tool to Aid Development, Evaluation of SARS-CoV-2 Tests americanpharmaceuticalreview
June 04, 2020
The U.S. Food and Drug Administration (FDA) took a new step to support the agency’s evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel.
IIT, BHU to re-purpose approved drugs from DrugBank database for treating COVID-19 expresspharma
June 04, 2020
The research group is working on developing new drug candidates against SARS-CoV-2 by exploring DrugBank database compounds as an inhibitor of SARS-CoV-2 main protease, a key enzyme required for SARS-CoV-2 assembly and multiplication.
Moleculin Provides Update on Coronavirus Drug Development americanpharmaceuticalreview
June 03, 2020
Moleculin Biotech announced the US Food and Drug Administration (FDA) has granted the Company's request for a Pre-IND Meeting to provide guidance regarding the Company's plan to study its drug candidate, WP1122 ...
FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit americanpharmaceuticalreview
June 01, 2020
Quest Diagnostics has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for the Quest Diagnostics Self-Collection Kit for COVID-19.
Israeli scientists say Gaucher’s disease drugs may help treat Covid-19 pharmaceutical-technology
May 29, 2020
Scientists from the Israeli Institute for Biological Research (IIBR) claim that analogues of two drugs used for the treatment of Gaucher’s disease could be effective against Covid-19.
Merck and Ridgeback Bio Collaborate contractpharma
May 28, 2020
Merck and Ridgeback Biotherapeutics LP, a closely held biotechnology company, have entered into a collaboration agreement to develop EIDD-2801.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page